Published in J Immunol Methods on June 01, 2001
Loss of T cell responses following long-term cryopreservation. J Immunol Methods (2007) 1.23
Cryopreservation: An emerging paradigm change. Organogenesis (2009) 0.95
Influence of Factors of Cryopreservation and Hypothermic Storage on Survival and Functional Parameters of Multipotent Stromal Cells of Placental Origin. PLoS One (2015) 0.77
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis (1989) 3.66
Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med (1989) 2.68
Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) (1986) 1.83
Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis (1989) 1.44
Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart (2005) 1.38
Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest (1992) 1.35
Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med (1996) 1.33
Systemic meningococcal disease: a model infection to study acute endotoxinemia in man. Prog Clin Biol Res (1988) 1.30
Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res (2001) 1.23
Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis (1992) 1.16
Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid. Antimicrob Agents Chemother (1981) 1.08
Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res (1985) 1.05
Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res (1990) 1.05
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis (1995) 0.99
Fish oil and plasma fibrinogen. BMJ (1988) 0.98
The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res (1989) 0.98
The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J Infect Dis (1996) 0.98
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res (1995) 0.97
Elevated VIP and endotoxin plasma levels in human gram-negative septic shock. Regul Pept (1989) 0.97
Total protein in common duct bile measured by acetonitrile precipitation and a micro bicinchoninic acid (BCA) method. Scand J Clin Lab Invest (1993) 0.95
LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein. Cytokine (1994) 0.94
Pharmacokinetic studies of antibacterial agents using the suction blister method. Scand J Infect Dis Suppl (1990) 0.94
Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide. J Endotoxin Res (2000) 0.94
Macrophage tropism: fact or fiction? J Leukoc Biol (1997) 0.93
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res (1993) 0.92
Different binding of 125I-LPS to plasma proteins from persons with high or low HDL. Scand J Clin Lab Invest (1996) 0.92
Significance of lipoproteins in serum binding variations of amitriptyline, nortriptyline, and quinidine. Clin Pharmacol Ther (1982) 0.91
DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet (1989) 0.91
Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood. Thromb Haemost (1996) 0.91
Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb Pathog (1992) 0.91
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91
Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int (1992) 0.90
LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine (1996) 0.89
Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg (1996) 0.89
Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest (2000) 0.88
Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes. Thromb Haemost (1996) 0.88
Drug binding in sera deficient in lipoproteins, albumin or orosomucoid. Br J Clin Pharmacol (1983) 0.88
Studies on soluble fibrin in plasma. I. N-terminal analysis of a modified fraction I (Cohn) from normal and thrombin-incubated plasma. Scand J Clin Lab Invest (1971) 0.87
Thrombin generation during collection and storage of blood. Vox Sang (1986) 0.87
Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide. Br J Clin Pharmacol (1984) 0.87
Fibrinemia in medical patients screened by the ethanol test. Acta Med Scand (1971) 0.86
Bacteremia and compartmentalization of LPS in meningococcal disease. Prog Clin Biol Res (1995) 0.86
Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study. Acta Endocrinol (Copenh) (1988) 0.85
Extreme plasminogen activator inhibitor and endotoxin values in patients with meningococcal disease. Thromb Res (1986) 0.84
Effect of monomethylmethacrylate on procoagulant activities of human monocytes and umbilical vein endothelial cells in vitro. Thromb Res (1994) 0.83
Tumour necrosis factor alpha and its promoter polymorphisms' role in the phenotypic expression of hemochromatosis. Scand J Gastroenterol (2003) 0.83
Retention of phagocytic functions in cryopreserved human monocytes. J Leukoc Biol (1995) 0.83
Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13. Cytokine (1996) 0.82
Binding and displacement of basic, acidic and neutral drugs in normal and orosomucoid-deficient plasma. Clin Pharmacokinet (1982) 0.82
Intrapulmonary thrombin generation and its relation to monomethylmethacrylate plasma levels during hip arthroplasty. Acta Anaesthesiol Scand (1992) 0.82
Calcium ionophore-induced de-encryption of tissue factor in monocytes is associated with extensive cell death. Thromb Res (2006) 0.82
Detection of small amounts of heparin by the thrombin clotting-time. Lancet (1972) 0.82
Effects of partially hydrogenated fish oil, partially hydrogenated soybean oil, and butter on serum lipoproteins and Lp[a] in men. J Lipid Res (1995) 0.82
Lipopolysaccharide-induced monocyte procoagulant activity, fibrinopeptide A, and PAI-I levels in persons with high or low levels of HDL-lipoprotein. Thromb Res (1993) 0.82
Fish-oil concentrate: effects on variables related to cardiovascular disease. Am J Clin Nutr (1990) 0.82
Studies on soluble fibrin in plasma. 3. N-terminal analysis of a modified fraction I (Cohn) from plasmin- and thrombin-incubated plasma. Scand J Clin Lab Invest (1973) 0.81
Studies on pathological plasma proteolysis in severely burned patients using chromogenic peptide substrate assays: a preliminary report. Adv Exp Med Biol (1984) 0.81
Fibrinaemia and multiple thrombi in pancreatic carcinoma. A case studied with quantitative N-terminal analysis. Scand J Haematol (1972) 0.81
A more accurate dye-binding method for the routine determination of serum albumin. Clin Chem (1979) 0.80
[The ethanol test--a sensitive indicator of intravascular coagulation]. Ginekol Pol (1970) 0.80
Heparin precipitable fraction (HPF) from dermatoligical patients. I. Characterization of the thrombin-clottable protein. Thromb Res (1976) 0.80
Polymerization properties of two normally circulating fibrinogens, HMW and LMW. Evidence that the COOH-terminal end of the a-chain is of importance for fibrin polymerization. Thromb Res (1985) 0.80
The influence of pH on heat denaturation of anti-haemophilic cryoprecipitate. Thromb Res (1987) 0.80
Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts. Clin Infect Dis (2000) 0.80
Incorporation of fibrinogen into soluble fibrin complexes. Thromb Res (1974) 0.80
Circulating lipopolysaccharides in the blood from "bioprotein" production workers. Occup Environ Med (2007) 0.79
Cardiovascular risk factors: interactive effects of lipids, coagulation and fibrinolysis. Scand J Clin Lab Invest Suppl (1993) 0.79
Ethanol gelation and fibrin monomers in plasma. Scand J Haematol Suppl (1971) 0.79
Precipitation of fibrinogen-derived material by protamine. Scand J Haematol Suppl (1971) 0.79
Studies on the plasma kallikrein-kinin system in peritoneal exudate and plasma during experimental acute pancreatitis in pigs. Scand J Gastroenterol (1985) 0.79
Generation of procoagulant (thromboplastin) and plasminogen activator activities in peripheral blood monocytes after total hip replacement surgery. Effects of high doses of corticosteroids. Thromb Res (1991) 0.79
Acute phase reactants and interleukin 6 after total hip replacement. Effects of high dose corticosteroids. Eur J Surg (1992) 0.79
Effects of doxazosin and atenolol on circulating endothelin-1 and von Willebrand factor in hypertensive middle-aged men. J Cardiovasc Pharmacol (1999) 0.78
Replacement of partially hydrogenated soybean oil by palm oil in margarine without unfavorable effects on serum lipoproteins. Lipids (1998) 0.78
The antiheparin effect of alpha 1-acid glycoprotein: influence on heparin tolerance during the acute phase reaction. Thromb Res (1982) 0.78
Studies on pathological plasma proteolysis in patients with acute pancreatitis. A preliminary report. Acta Chir Scand Suppl (1982) 0.78
Systemic thrombin generation and activity resistant to low molecular weight heparin administered prior to streptokinase in patients with acute myocardial infarction. Thromb Haemost (1997) 0.78
Sensitive and specific radioimmunoassay for creatine kinase BB isoenzyme in serum, with use of an autoantibody. Clin Chem (1981) 0.78